[1]Patent:WO2008/68231,2008,A1.Locationinpatent:Page/Pagecolumn16
[2]Patent:US2018/265473,2018,A1.Locationinpatent:Paragraph0085;0086
[1]CurrentPatentAssignee:VIATRISINC-WO2020/161743,2020,A1
[1]CurrentPatentAssignee:VIATRISINC-WO2020/161743,2020,A1
[1]CurrentPatentAssignee:VIATRISINC-WO2020/161743,2020,A1
[1]CurrentPatentAssignee:VIATRISINC-WO2020/161743,2020,A1
Title: Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
Journal: Antimicrobial agents and chemotherapy 20140101
Title: 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
Journal: Lancet (London, England) 20120915
Title: Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120415
Title: Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Journal: PloS one 20120101
Title: Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection.
Journal: American journal of respiratory and critical care medicine 20110915
Title: The TB Alliance: overcoming challenges to chart the future course of TB drug development.
Journal: Future medicinal chemistry 20110801
Title: Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis.
Journal: PloS one 20110101
Title: Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.
Journal: PloS one 20110101
Title: [Present and future in the use of anti-tubercular drugs].
Journal: Pneumologia (Bucharest, Romania) 20110101
Title: Drugs in development for tuberculosis.
Journal: Drugs 20101203
Title: Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101201
Title: Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells.
Journal: Tuberculosis (Edinburgh, Scotland) 20100901
Title: [R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].
Journal: Medecine et maladies infectieuses 20100701
Title: In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.
Journal: Antimicrobial agents and chemotherapy 20100701
Title: Current development and future prospects in chemotherapy of tuberculosis.
Journal: Respirology (Carlton, Vic.) 20100701
Title: TMC207: the first compound of a new class of potent anti-tuberculosis drugs.
Journal: Future microbiology 20100601
Title: Update in tuberculosis 2009.
Journal: American journal of respiratory and critical care medicine 20100315
Title: Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.
Journal: American journal of respiratory and critical care medicine 20090915
Title: Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry 20090401
Title: A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.
Journal: American journal of respiratory and critical care medicine 20090101
Title: Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.
Journal: American journal of respiratory and critical care medicine 20090101
Title: [Some new antitubercular agents].
Journal: Revue medicale suisse 20080319
Title: New anti-tuberculosis drugs with novel mechanisms of action.
Journal: Current medicinal chemistry 20080101
Title: In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor.
Journal: Antimicrobial agents and chemotherapy 20071101
Title: New tuberculosis therapeutics: a growing pipeline.
Journal: The Journal of infectious diseases 20070815
Title: A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910.
Journal: Proteins 20070601
Title: A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
Journal: Science (New York, N.Y.) 20050114
Title: Microbiology. TB--a new target, a new drug.
Journal: Science (New York, N.Y.) 20050114
Title: Medicine. New TB drug promises shorter, simpler treatment.
Journal: Science (New York, N.Y.) 20041210
Title: Jang JC, et al. Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis. J Microbiol. 2017 Apr 20.
Title: Chahine EB, et al. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother. 2014 Jan;48(1):107-15.
Title: Pang Y, et al. In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China. Antimicrob Agents Chemother. 2017 Apr 24;61(5).
